Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.2031 -0.0148 (-6.79%)

Streaming Delayed Price Updated: 10:32 AM EDT, May 28, 2026 Add to My Watchlist

Price and Volume

Volume	1,889,631
Open	0.2106
Bid (Size)	0.2031 (60,000)
Ask (Size)	0.2032 (6,500)
Prev. Close	0.2179
Today's Range	0.2015 - 0.2130
52wk Range	0.1626 - 3.870
Shares Outstanding	75,993,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Today 10:05 EDT

From Schall Law

Via GlobeNewswire

GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

May 27, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Performance

YTD	-92.9%	-92.9%
1 Month	-41.7%	-41.7%
3 Month	-46.6%	-46.6%
6 Month	-93.9%	-93.9%
1 Year	-81.9%	-81.9%

More News

Gossamer Bio (GOSS) Q1 2026 Earnings Transcript ↗

May 27, 2026

Via The Motley Fool

Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st

May 26, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

May 26, 2026

From Pomerantz LLP

Via GlobeNewswire

DEADLINE APPROACHING: Berger Montague Advises Gossamer Bio, Inc. (NASDAQ: GOSS) Investors to Inquire About a Securities Fraud Class Action by June 1, 2026

May 26, 2026

From Berger Montague

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 25, 2026

From Schall Law

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 21, 2026

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

May 19, 2026

From Pomerantz LLP

Via GlobeNewswire

These stocks are moving in today's session ↗

May 18, 2026

Via Chartmill

GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

May 18, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 18, 2026

Via Chartmill

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 18, 2026

From Schall Law

Via GlobeNewswire

Which stocks are gapping on Monday? ↗

May 18, 2026

Via Chartmill

Gossamer Bio Q1 Earnings Call Highlights ↗

May 18, 2026

Via MarketBeat

Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support

May 18, 2026

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update

May 18, 2026

From Gossamer Bio, Inc.

Via Business Wire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 15, 2026

From Schall Law

Via GlobeNewswire

Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026

May 15, 2026

From Gossamer Bio, Inc.

Via Business Wire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

May 13, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS

May 12, 2026

From Pomerantz LLP

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 12, 2026

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm

May 11, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

May 10, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 08, 2026

From Schall Law

Via GlobeNewswire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?

Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.

What exchange does Gossamer Bio, Inc. - Common Stock trade on?

Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?

The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market

What is the current price of Gossamer Bio, Inc. - Common Stock?

The current price of Gossamer Bio, Inc. - Common Stock is 0.2031

When was Gossamer Bio, Inc. - Common Stock last traded?

The last trade of Gossamer Bio, Inc. - Common Stock was at 05/28/26 10:32 AM ET

What is the market capitalization of Gossamer Bio, Inc. - Common Stock?

The market capitalization of Gossamer Bio, Inc. - Common Stock is 15.43M

How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?

Gossamer Bio, Inc. - Common Stock has 15M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.